Log In
BCIQ
Print this Print this
 

PF-04958242, PF-4958242

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionAMPA glutamate receptor (GRIA) (GLUR) agonist
Molecular Target AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today